{"date":"2025-03-11","count":66,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6838-2025-03-11-2331-13f6o7m","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"23:31:08","subject":"公告董事會決議設置永續發展委員會及委任委員會成員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-03-11 23:31，「公告董事會決議設置永續發展委員會及委任委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-03-11-2330-tulf6t","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"23:30:43","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-03-11 23:30，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-03-11-2330-3kb7gv","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"23:30:17","subject":"本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-03-11 23:30，「本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-03-11-2329-1hku5w3","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"23:29:40","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-03-11 23:29，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-03-11-2204-1sbdmgt","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"22:04:05","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-03-11 22:04，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-03-11-2203-g0mtjm","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"22:03:40","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-03-11 22:03，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2025-03-11-2120-1olouxn","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"21:20:12","subject":"公告本公司接獲衛生福利部通知終止「EBaT8」臨床試驗執行相關事宜。","clause":"第44款","fact_date":"2025-03-11","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2025-03-11 21:20，「公告本公司接獲衛生福利部通知終止「EBaT8」臨床試驗執行相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-11-2044-np8q9t","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"20:44:29","subject":"公告本公司董事會決議召開股東會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-11 20:44，「公告本公司董事會決議召開股東會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-03-11-2030-1v08jg1","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"20:30:48","subject":"公告本公司董事會決議辦理私募發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-03-11 20:30，「公告本公司董事會決議辦理私募發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-03-11-2030-1juywul","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"20:30:15","subject":"公告本公司董事會決議召開114年股東常會日期暨相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-03-11 20:30，「公告本公司董事會決議召開114年股東常會日期暨相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-03-11-2029-10fn4ra","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"20:29:29","subject":"公告本公司董事會重大決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-03-11 20:29，「公告本公司董事會重大決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-03-11-2028-11wjw0o","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"20:28:51","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-03-11 20:28，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-03-11-2027-1dmdgdo","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"20:27:50","subject":"公告本公司董事會通過113年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-03-11 20:27，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-11-2024-1tbdzk2","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"20:24:12","subject":"公告本公司董事會通過113年第4季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-11 20:24，「公告本公司董事會通過113年第4季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-11-2023-1fddb6k","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"20:23:04","subject":"公告本公司董事會決議發行限制員工權利新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-11 20:23，「公告本公司董事會決議發行限制員工權利新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-11-2022-17up2wc","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"20:22:39","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-11 20:22，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-11-2022-ovyukb","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"20:22:03","subject":"本公司董事會決議不分配113年度員工酬勞及董事酬勞","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-11 20:22，「本公司董事會決議不分配113年度員工酬勞及董事酬勞」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-11-2021-192h74v","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"20:21:31","subject":"本公司113年度累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-11 20:21，「本公司113年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-11-2020-3kb7gv","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"20:20:47","subject":"本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-11 20:20，「本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-11-2016-1sakp2d","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"20:16:08","subject":"法人董事指派代表人出席114/03/11董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-11 20:16，「法人董事指派代表人出席114/03/11董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-03-11-1936-1t5gay1","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"19:36:18","subject":"本公司受邀參加櫃買中心舉辦之業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-03-11 19:36，「本公司受邀參加櫃買中心舉辦之業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-03-11-1910-ldk656","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"19:10:14","subject":"公告本公司董事會決議113年下半年度股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-03-11 19:10，「公告本公司董事會決議113年下半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-03-11-1900-nob2a5","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"19:00:59","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-03-11 19:00，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-03-11-1858-1expjqi","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:58:41","subject":"公告本公司董事會決議召開114年度股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-03-11 18:58，「公告本公司董事會決議召開114年度股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-03-11-1854-179escn","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:54:06","subject":"公告本公司董事會通過113年合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-03-11 18:54，「公告本公司董事會通過113年合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-03-11-1848-6hjnsb","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:48:23","subject":"董事會決議召開114年股東常會(增加議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-03-11 18:48，「董事會決議召開114年股東常會(增加議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1841-bwopfv","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:41:35","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 18:41，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-03-11-1841-bwopfv","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:41:12","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-03-11 18:41，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-03-11-1840-1hku5w3","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:40:42","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-03-11 18:40，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-03-11-1838-11wjw0o","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:38:03","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-03-11 18:38，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-03-11-1831-iy9voq","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:31:48","subject":"本公司113年度合併財務報告已提報董事會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-03-11 18:31，「本公司113年度合併財務報告已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-03-11-1804-1u7pahz","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"18:04:45","subject":"董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-03-11 18:04，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-03-11-1803-1j23cjx","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"18:03:27","subject":"本公司董事會決議召開114年股東常會相關事宜公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-03-11 18:03，「本公司董事會決議召開114年股東常會相關事宜公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-03-11-1803-1u7pahz","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"18:03:06","subject":"董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-03-11 18:03，「董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-03-11-1803-obk2ke","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"18:03:02","subject":"代子公司歐帕生技醫藥股份有限公司公告執行長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-03-11 18:03，「代子公司歐帕生技醫藥股份有限公司公告執行長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-03-11-1802-3rc8x5","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"18:02:45","subject":"本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-03-11 18:02，「本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7595-2025-03-11-1756-1imb5qg","company_id":"7595","company":"世基生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"17:56:32","subject":"公告本公司發言人/代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：世基生醫（7595），2025-03-11 17:56，「公告本公司發言人/代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-11-1744-fn5aok","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:44:55","subject":"本公司受邀參加富邦證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-11 17:44，「本公司受邀參加富邦證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1725-1gk9xif","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:25:01","subject":"代子公司瑞亞生醫(股)公司公告董事會(代行股東會職權)重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 17:25，「代子公司瑞亞生醫(股)公司公告董事會(代行股東會職權)重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1723-puuep8","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:23:48","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 17:23，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1722-1enknwp","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:22:51","subject":"代子公司瑞亞生醫(股)公司公告董事會決議113年度不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 17:22，「代子公司瑞亞生醫(股)公司公告董事會決議113年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1722-1r332wi","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:22:21","subject":"更正本公司112年9月至113年12月合併營收公告暨補更正自112年第3季至113年第3季各季度合併財務報告暨個體財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 17:22，「更正本公司112年9月至113年12月合併營收公告暨補更正自112年第3季至113年第3季各季度合併財務報告暨個體財務報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1722-j9i1h2","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:22:03","subject":"公告本公司獨立董事任期達三屆續提名說明","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 17:22，「公告本公司獨立董事任期達三屆續提名說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1721-p67uuk","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:21:36","subject":"公告本公司內部稽核主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 17:21，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1717-1dc0qrw","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:17:55","subject":"公告本公司董事會通過113年第4季合併財報務告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 17:17，「公告本公司董事會通過113年第4季合併財報務告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-03-11-1717-tulf6t","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:17:26","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-03-11 17:17，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-03-11-1714-13c3d3u","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"17:14:22","subject":"本公司董事會決議召開股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-03-11 17:14，「本公司董事會決議召開股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-03-11-1658-jlx27i","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:58:48","subject":"代本公司之重要子公司威茂(股)公司公告董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-03-11 16:58，「代本公司之重要子公司威茂(股)公司公告董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-03-11-1658-1dikn9j","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:58:16","subject":"代子公司威茂股份有限公司公告董事會(代行股東會職權)重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-03-11 16:58，「代子公司威茂股份有限公司公告董事會(代行股東會職權)重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-03-11-1640-1iiuf4f","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:40:14","subject":"本公司114年股東會召開日期及召集事由","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-03-11 16:40，「本公司114年股東會召開日期及召集事由」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-03-11-1638-10ucyw9","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:38:57","subject":"本公司董事會決議辦理現金增資私募普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-03-11 16:38，「本公司董事會決議辦理現金增資私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-03-11-1637-jrxalj","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:37:32","subject":"本公司董事會決議113年股東常會通過之私募現金增資發行普通股案不繼續辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-03-11 16:37，「本公司董事會決議113年股東常會通過之私募現金增資發行普通股案不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-03-11-1637-phvuhx","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:37:08","subject":"公告本公司董事會通過民國113年合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-03-11 16:37，「公告本公司董事會通過民國113年合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-03-11-1636-nob2a5","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:36:49","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-03-11 16:36，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-03-11-1636-13bqai2","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:36:17","subject":"本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-03-11 16:36，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-03-11-1636-1nyfa2n","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:36:05","subject":"本公司對子公司杏州醫藥股份有限公司資金貸與案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-03-11 16:36，「本公司對子公司杏州醫藥股份有限公司資金貸與案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-03-11-1635-3rc8x5","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:35:21","subject":"本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-03-11 16:35，「本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-03-11-1630-11wjw0o","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:30:13","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-03-11 16:30，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-03-11-1622-1sqb5rs","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:22:33","subject":"公告財務主管、會計主管、公司治理主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-03-11 16:22，「公告財務主管、會計主管、公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-03-11-1621-1fgt9r6","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:21:55","subject":"公告本公司不繼續辦理113年股東常會通過之私募普通股或私募國內無擔保可轉換公司債案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-03-11 16:21，「公告本公司不繼續辦理113年股東常會通過之私募普通股或私募國內無擔保可轉換公司債案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-03-11-1620-1vgpz2i","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:20:56","subject":"公告本公司董事會決議召開民國114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-03-11 16:20，「公告本公司董事會決議召開民國114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6661-2025-03-11-1601-1yfr78c","company_id":"6661","company":"威健生技","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"16:01:59","subject":"公告本公司113年度合併財務報告經董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威健生技（6661），2025-03-11 16:01，「公告本公司113年度合併財務報告經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-03-11-1543-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"15:43:19","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-03-11 15:43，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-03-11-1508-j6gyo8","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-03-11","time":"15:08:22","subject":"代重要子公司Belite Bio, Inc公告113年第4季法人說明會將於114年3月18日召開","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-03-11 15:08，「代重要子公司Belite Bio, Inc公告113年第4季法人說明會將於114年3月18日召開」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-03-11-1430-1wshgwv","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-03-11","time":"14:30:27","subject":"公告本公司董事會決議通過解除經理人競業禁止之限制","clause":"第21款","fact_date":"2025-02-26","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-03-11 14:30，「公告本公司董事會決議通過解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-03-11-1414-d3cofy","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-03-11","time":"14:14:40","subject":"公告本公司財務主管、會計主管、公司治理主管、代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-03-11 14:14，「公告本公司財務主管、會計主管、公司治理主管、代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}